Cargando…
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Unmet needs in the treatment of psoriasis call for novel therapeutic strategies. Pustular psoriasis and psoriatic arthritis often represent a therapeutic challenge. Focus on IL-36 cytokines offers an interesting approach, as the IL-36 axis has been appointed a critical driver of the autoinflammatory...
Autores principales: | Iznardo, Helena, Puig, Lluís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122427/ https://www.ncbi.nlm.nih.gov/pubmed/33919434 http://dx.doi.org/10.3390/ijms22094344 |
Ejemplares similares
-
Dual inhibition of IL-17A and IL-17F in psoriatic disease
por: Iznardo, Helena, et al.
Publicado: (2021) -
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
por: Iznardo, Helena, et al.
Publicado: (2022) -
Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023) -
IL-36 cytokines in autoimmunity and inflammatory disease
por: Ding, Liping, et al.
Publicado: (2017) -
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)